|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-1-19
|
|
pubmed:abstractText |
The prognostic significance of germline BRCA1 and BRCA2 mutations in Jewish patients with pancreatic adenocarcinoma (PAC) is unknown. Our objective was to define the prevalence of BRCA1 and BRCA2 in an unselected group of Jewish patients and to compare the clinical characteristics and overall survival (OS) of patients with resected BRCA mutation-associated PAC to PAC patients without mutations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
433-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19064968-Adenocarcinoma,
pubmed-meshheading:19064968-Adult,
pubmed-meshheading:19064968-Aged,
pubmed-meshheading:19064968-Aged, 80 and over,
pubmed-meshheading:19064968-Female,
pubmed-meshheading:19064968-Founder Effect,
pubmed-meshheading:19064968-Genes, BRCA1,
pubmed-meshheading:19064968-Genes, BRCA2,
pubmed-meshheading:19064968-Humans,
pubmed-meshheading:19064968-Jews,
pubmed-meshheading:19064968-Male,
pubmed-meshheading:19064968-Middle Aged,
pubmed-meshheading:19064968-Mutation,
pubmed-meshheading:19064968-Pancreatic Neoplasms
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
|
|
pubmed:publicationType |
Journal Article
|
